CAS 2225938-17-8

MS1943

CAS: 2225938-17-8

Formel: C₄₂H₅₄N₈O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 718.9300

Ref: IN-DA01N607

6-(6-(4-(2-(2-(Adamantan-1-Yl)Acetamido)Ethyl)Piperazin-1-Yl)Pyridin-3-Yl)-N-((4,6-Dimethyl-2-Oxo-1,2-Dihydropyridin-3-Yl)Methyl)-1-Isopropyl-1H-Indazole-4-Carboxamide

CAS: 2225938-17-8

6-(6-(4-(2-(2-(Adamantan-1-Yl)Acetamido)Ethyl)Piperazin-1-Yl)Pyridin-3-Yl)-N-((4,6-Dimethyl-2-Oxo-1,2-Dihydropyridin-3-Yl)Methyl)-1-Isopropyl-1H-Indazole-4-Carboxamide

Reinheit: 98%

Molekulargewicht: 718.93g/mol

Ref: 54-OR1022968

MS1943

CAS: 2225938-17-8

MS1943

Reinheit: ≥95%

Molekulargewicht: 718.93g/mol

Ref: 54-BUP09062

MS1943

CAS: 2225938-17-8

MS1943 is a orally bioavailable EZH2 selective degrader(IC50 of 120 nM).

Formel: C₄₂H₅₄N₈O₃

Reinheit: 95.41% - 95.82%

Farbe und Form: Solid

Molekulargewicht: 718.93

Ref: TM-T13780

MS1943

Kontrolliertes Produkt

CAS: 2225938-17-8

Formel: C₄₂H₅₄N₈O₃

Farbe und Form: Neat

Molekulargewicht: 718.93

Ref: TR-M495560

MS1943

CAS: 2225938-17-8

MS1943 is a monoclonal antibody that binds to the HER2 receptor and inhibits the growth of breast cancer cells. MS1943 is currently in clinical trials for its potential use as a biomarker in patients with HER2+ breast cancer. The drug has been shown to bind to a variety of targets, including response elements and intracellular targets. It also binds to both the extracellular domain of the HER2 receptor and the intracellular domain of the HER2 receptor. MS1943 binds to many different subunits, including dimeric forms of HER2 receptors, which may be responsible for its success against certain types of breast cancers.

Formel: C₄₂H₅₄N₈O₃

Reinheit: Min. 95%

Molekulargewicht: 718.93 g/mol

Ref: 3D-APD93817